Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin

Details for Australian Patent Application No. 2005309651 (hide)

Owner AMR Technology, Inc.

Inventors Molino, Bruce F.; Cohen, Marlene; Berkowitz, Barry

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005309651

PCT Pub. Number WO2006/058016

Priority 10/994,956 22.11.04 US

Filing date 21 November 2005

Wipo publication date 1 June 2006

International Classifications

A61K 31/47 (2006.01) - Quinolines

Event Publications

5 July 2007 PCT application entered the National Phase

  PCT publication WO2006/058016 Priority application(s): WO2006/058016

19 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005309652-Transmucosal oral delivery device

2005309649-Harnessing network biology to improve drug discovery